Cherel, Michel
494  results:
Search for persons X
?
2

Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR fo..:

Pizzonero, Mathieu ; Akkari, Rhalid ; Bock, Xavier...
Journal of Medicinal Chemistry.  67 (2024)  7 - p. 5216-5232 , 2024
 
?
8

Preclinical Evaluation of a 64Cu-Based Theranostic Approach..:

Métivier, Cassandra ; Le Saëc, Patricia ; Gaschet, Joëlle...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15071817.  , 2023
 
?
9

Assessment of hypoxia and oxidative-related changes in a lu..:

Fantin, Jade ; Toutain, Jérôme ; Pérès, Elodie A...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13550-023-01052-8.  , 2023
 
?
10

"New Modalities in Cancer Imaging and Therapy\" XVth editio..:

Léost, Françoise ; Barbet, Jacques ; Beyler, Maryline...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.bulcan.2023.08.007.  , 2023
 
?
11

Assessment of hypoxia and oxidative-related changes in a lu..:

Fantin, Jade ; Toutain, Jérôme ; Pérès, Elodie A...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13550-023-01052-8.  , 2023
 
?
12

Preclinical Evaluation of a 64Cu-Based Theranostic Approach..:

Métivier, Cassandra ; Le Saëc, Patricia ; Gaschet, Joëlle...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15071817.  , 2023
 
?
13

Preclinical Evaluation of a 64Cu-Based Theranostic Approach..:

Métivier, Cassandra ; Le Saëc, Patricia ; Gaschet, Joëlle...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15071817.  , 2023
 
?
 
1-15